You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Details for New Drug Application (NDA): 084915

✉ Email this page to a colleague

« Back to Dashboard

NDA 084915 describes FOLIC ACID, which is a drug marketed by Ben Venue, Fresenius Kabi Usa, Xgen Pharms, Aiping Pharm Inc, Amneal Pharm, Barr, Cadila Pharms Ltd, Chartwell Molecular, Contract Pharmacal, Everylife, Halsey, Hikma Pharms, Impax Labs, Ivax Sub Teva Pharms, Jubilant Cadista, Lannett, Leading, Lilly, Mk Labs, Nexgen Pharma Inc, Nuvo Pharms Inc, Ph Health, Pharmeral, Pioneer Pharms, Purepac Pharm, Rising, Sandoz, Sun Pharm Industries, Tablicaps, UDL, Usl Pharma, Valeant Pharm Intl, Vangard, Vintage Pharms, Watson Labs, and Whiteworth Town Plsn, and is included in thirty-eight NDAs. It is available from twenty-eight suppliers. Additional details are available on the FOLIC ACID profile page.

The generic ingredient in FOLIC ACID is folic acid. There are ten drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the folic acid profile page.

Summary for 084915

Tradename:	FOLIC ACID
Applicant:	Nexgen Pharma Inc
Ingredient:	folic acid
Patents:	0

Medical Subject Heading (MeSH) Categories for 084915

Hematinics
Vitamin B Complex

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	1MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.